Neuroscience News and Research

RSS

Grand Valley researcher receives grant to study molecular biomarkers to monitor Parkinson's disease

A researcher at Grand Valley State University has received a grant to continue studying if molecular biomarkers can be used to monitor the advancement of Parkinson's disease.

3 Oct 2014

Placenta-derived cells are safe for MS patients

Patients with Multiple Sclerosis (MS) were able to safely tolerate treatment with cells cultured from human placental tissue, according to a study published today in the journal Multiple Sclerosis and Related Disorders.

1 Oct 2014

Salk researchers receive BRAIN Initiative funding

Joseph Ecker, a Salk professor and Howard Hughes Medical Institute investigator, and Margarita Behrens, Salk staff scientist, have been named recipients in the 2014 round of grants from the National Institutes of Health (NIH) through the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative for leading-edge work in neuroscience.

1 Oct 2014

West Virginia University receives NIH award as part of BRAIN initiative

In its first wave of funding awards, a new presidential project aimed at revolutionizing our understanding of the human brain has pledged its support to a group of researchers led by West Virginia University faculty working to change the future of brain imaging.

1 Oct 2014

NPI leaders to invest more than $30M to support White House BRAIN Initiative

Leaders of the National Photonics Initiative (NPI), an alliance of top scientific societies uniting industry and academia to raise awareness of photonics, launched its Photonics Industry Neuroscience Group alongside officials from the White House Office of Science and Technology (OSTP) in conjunction with today's White House BRAIN Initiative conference.

30 Sep 2014

New study reports how TMS treatment works in people with depression

On Star Trek, it is easy to take for granted the incredible ability of futuristic doctors to wave small devices over the heads of both humans and aliens, diagnose their problems through evaluating changes in brain activity or chemistry, and then treat behavior problems by selectively stimulating relevant brain circuits.

30 Sep 2014

Johnson & Johnson inks definitive deal to acquire Alios BioPharma

Johnson & Johnson today announced a definitive agreement to acquire Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.75 billion in cash.

30 Sep 2014

Moberg receives CE Mark approval for CNS Monitor

Moberg has received CE Mark approval for the CNS Monitor, a medical device used for advanced monitoring of neurological intensive care patients. The CE Mark certifies that a product has met European Union requirements for commercial marketing in Europe.

30 Sep 2014

Brain & Behavior Research Foundation to honor 8 scientists for achievements in psychiatric research

The Brain & Behavior Research Foundation will honor eight scientists with its 2014 Outstanding Achievement Prizes for work delving into psychiatric disorders that affect one in four people. The awards, which celebrate the transformative power of neuroscience and psychiatric research to improve the lives of people with mental illness, will be presented at the Foundation's National Awards Dinner at the Pierre Hotel.

30 Sep 2014

AAN releases new position statement on opioids for chronic non-cancer pain

According to a new position statement from the American Academy of Neurology, the risk of death, overdose, addiction or serious side effects with prescription opioids outweigh the benefits in chronic, non-cancer conditions such as headache, fibromyalgia and chronic low back pain.

30 Sep 2014

Research!America to recognize distinguished research advocates with Advocacy Awards

Research!America's 19th annual Advocacy Awards will honor distinguished research advocates who are trailblazers in advancing medical progress to improve the health and economic security of our nation. The event will take place on Wednesday, March 11, 2015, at the Andrew W. Mellon Auditorium in Washington, DC.

30 Sep 2014

Phase 3 COU-AA-302 results show ZYTIGA plus prednisone prolongs overall survival in men with chemotherapy-naive mCRPC

A final analysis of the Phase 3 COU-AA-302 trial presented today at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain showed that ZYTIGA® (abiraterone acetate) plus prednisone significantly prolonged overall survival (OS), compared to an active control of placebo plus prednisone, in men with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).

30 Sep 2014

Neural recordings can be used to forecast spontaneous decisions

You're waiting at a bus stop, expecting the bus to arrive any time. You watch the road. Nothing yet. A little later you start to pace. More time passes. "Maybe there is some problem", you think. Finally, you give up and raise your arm and hail a taxi. Just as you pull away, you glimpse the bus gliding up. Did you have a choice to wait a bit longer? Or was giving up too soon the inevitable and predictable result of a chain of neural events?

30 Sep 2014

Scientists show how individual neurons in the human brain react to morphed faces

An international team of scientists, involving Professor Rodrigo Quian Quiroga, director of the Centre for Systems Neuroscience and Head of Bioengineering at the University of Leicester, has shown how individual neurons in the human brain react to ambiguous morphed faces.

29 Sep 2014

EnteroMedics' CE Mark for Maestro System expanded to include management of Type 2 diabetes mellitus

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro Rechargeable (RC) System for obesity was expanded to include the management of Type 2 diabetes mellitus through improved glycemic control.

29 Sep 2014

Understanding how neurons encode information

Nathan Urban, interim provost and the Dr. Frederick A. Schwertz Distinguished Professor of Life Sciences, and Robert Kass, professor of statistics and machine learning, have received a $930,000 grant from the National Science Foundation to apply biological and statistical neuroscience approaches in order to create a better overall understanding of how neurons encode information.

29 Sep 2014

Dr. Nancy Chiaravalloti of Kessler Foundation receives Alumni Achievement in Science award

Nancy (Donofrio) Chiaravalloti, PhD, of Kessler Foundation received the Alumni Achievement in Science award from her alma mater, Muhlenberg College at the Alumni Association luncheon on September 13th.

27 Sep 2014

Study findings have potential to advance treatments for small cell lung cell cancer

Two recently published studies by a research team at University Hospitals Case Medical Center Seidman Cancer Center have the potential to advance treatments for small cell lung cell cancer (SCLC). This aggressive form of lung cancer has seen no treatment advances in 30 years and "is a disease in urgent need of new drug therapies," write the study's authors.

26 Sep 2014

Study shows how complex tactile sensations are coded at cellular level in brain

The traditional understanding in neuroscience is that tactile sensations from the skin are only assembled to form a complete experience in the cerebral cortex, the most advanced part of the brain.

26 Sep 2014

People with memory loss more likely to develop dementia later, study finds

New research suggests that people without dementia who begin reporting memory issues may be more likely to develop dementia later, even if they have no clinical signs of the disease.

25 Sep 2014

Neuroscience News and Research

Grand Valley researcher receives grant to study molecular biomarkers to monitor Parkinson's disease

Placenta-derived cells are safe for MS patients

Salk researchers receive BRAIN Initiative funding

West Virginia University receives NIH award as part of BRAIN initiative

NPI leaders to invest more than $30M to support White House BRAIN Initiative

New study reports how TMS treatment works in people with depression

Johnson & Johnson inks definitive deal to acquire Alios BioPharma

Moberg receives CE Mark approval for CNS Monitor

Brain & Behavior Research Foundation to honor 8 scientists for achievements in psychiatric research

AAN releases new position statement on opioids for chronic non-cancer pain

Research!America to recognize distinguished research advocates with Advocacy Awards

Phase 3 COU-AA-302 results show ZYTIGA plus prednisone prolongs overall survival in men with chemotherapy-naive mCRPC

Neural recordings can be used to forecast spontaneous decisions

Scientists show how individual neurons in the human brain react to morphed faces

EnteroMedics' CE Mark for Maestro System expanded to include management of Type 2 diabetes mellitus

Understanding how neurons encode information

Dr. Nancy Chiaravalloti of Kessler Foundation receives Alumni Achievement in Science award

Study findings have potential to advance treatments for small cell lung cell cancer

Study shows how complex tactile sensations are coded at cellular level in brain

People with memory loss more likely to develop dementia later, study finds

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News